I/we have a beneficial long position in the shares of TLT, XBI either through stock ownership, options, or other derivatives.

Source: https://seekingalpha.com/article/4591663-spuu-leveraged-etfs-april-drift-dashboard?source=feed_all_articles

We must underline that while the XBI ETF offers exposure to a dynamic industry, it is not without its share of risks.

Source: https://seekingalpha.com/article/4614746-xbi-vehicle-transformative-benefits-artificial-intelligence-within-biotechnology?source=feed_all_articles

While the XBI is still trading 50% below its February 2021 closing high, analysts believe the downturn in biotech has bottomed out.

Source: https://financialpost.com/pmn/business-pmn/biotech-ipos-to-bloom-with-spotlight-on-startups-with-human-trial-data

XBI is the non-leveraged exchange-traded fund ("ETF") of the Biotechnology Select Industry Index.

Source: https://seekingalpha.com/article/4595042-leveraged-biotech-etfs-hold-labu-sell-labd?source=feed_all_articles